Tous Actualités
Suivre
Abonner eyeforpharma

eyeforpharma

Managing Uncertainty; a Migraine for Pharma Forecasters

London, May 7, 2010 (ots/PRNewswire)

Forecasting in pharmaceuticals
has its up's and down's, with new markets and products proving more
complex and requiring sophisticated approaches to forecast these
areas.
Dealing with uncertainties is no easy task. With a number of
risks to consider, pharmaceutical forecasting teams need to be able
to recognise commercial uncertainties surrounding a given product,
capture it and manage the associated risk.
"As recent times have demonstrated the future is uncertain, but
we have to make decision now," says Nich Guthrie, Head of Forecasting
- Global Marketing, AstraZeneca. "How we handle uncertainty, and not
be paralysed by it, is critical to making good investment decisions."
Adopting successful risk management strategies and scenario
analysis techniques can turn information into something more
meaningful when tackling this challenge. Guthrie will discuss his
experience and ideas on this very topic at the Pharma Forecasting
Excellence summit in Zurich.
With a view to bringing key topics and innovations in forecasting
to the forefront, Pharma Forecasting Excellence Europe 2010, 8-9th
June, Zurich, presents best practices from pioneers in the industry.
A particular highlight will be Christian Naumann, VP Global
Commercial Operations at Bayer-Schering who will be discussing their
forecasting process and how to maximise the value for a global
business.
To view the full discussion visit
http://www.eyeforpharma.com/forecastingeu
Media contact: Puja Pankhania - VP Europe, eyeforpharma,  T:
+44(0)207-375-7563, E:  Puja@eyeforpharma.com

Contact:

CONTACT: Media contact: Puja Pankhania - VP Europe, eyeforpharma,
T:+44(0)207-375-7563, E: Puja@eyeforpharma.com